Hannah Peters

Title: Innovations of Inventor Hannah Peters

Introduction

Hannah Peters is a notable inventor based in Baltimore, MD (US). She has made significant contributions to the field of antiviral research, particularly in the development of nucleoside analogues. With a total of 2 patents to her name, her work focuses on innovative methods to combat viral infections.

Latest Patents

Hannah Peters' latest patents include the design, synthesis, and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity. This invention is directed towards compounds, methods, and compositions for treating or preventing viral infections using nucleoside analogs. Specifically, it provides for the design and synthesis of acyclic fleximer nucleoside analogues that exhibit increased flexibility and the ability to alter their conformation structures. This innovation aims to enhance antiviral activity potential, resulting in the inhibition of several coronaviruses.

Career Highlights

Throughout her career, Hannah has worked with esteemed institutions such as the University System of Maryland and Katholieke Universiteit Leuven/Leiden University Medical Center in Rc Leiden. Her research has been pivotal in advancing the understanding of antiviral compounds and their applications.

Collaborations

Hannah Peters has collaborated with notable professionals in her field, including Katherine L. Radtke and Johan Neyts. These collaborations have further enriched her research and contributed to her innovative work.

Conclusion

Hannah Peters is a distinguished inventor whose work in antiviral research has the potential to make a significant impact on public health. Her innovative patents and collaborations highlight her dedication to advancing scientific knowledge and developing effective treatments for viral infections.